Member access

4-Traders Homepage  >  News

News

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesHot NewsMost Read NewsRecomm.Business LeadersVideosCalendar 
The feature you requested does not exist. However, we suggest the following feature:

Horizon Discovery : Transgenomic to incorporate Horizon Discovery’s Genomic Reference Standards into Multiplexed ICE COLD-PCR™ kits

04/26/2015 | 02:15am US/Eastern

23/04/2015

Transgenomic to incorporate Horizon Discovery's Genomic Reference Standards into
Multiplexed ICE COLD-PCR™ kits

Horizon to provide human genomic reference standards to assure quality and performance of Transgenomic's Multiplexed ICE COLD-PCR kits

CAMBRIDGE, UK, and OMAHA, NE, USA (April, 23, 2015) --Horizon Discovery Group plc (LSE:HZD) (Horizon), the international life science company supplying research tools and services that power genomics research and the development of personalized medicines, and Transgenomic, Inc. (NASDAQ: TBIO), a global biotechnology company advancing personalized medicine in cardiology, oncology and inherited diseases through advanced diagnostic tests and clinical and research services, today announced a new Original Equipment Manufacture (OEM) agreement to incorporate Horizon's human genomic reference standards, produced by Horizon's Diagnostics division, into Transgenomic's Multiplexed ICE COLD-PCRTM (MX-ICP) kits for use in research and clinical applications. Further details of the agreement were not disclosed.

This agreement follows a collaborative project initiated last year between Horizon's Diagnostics division and Transgenomic, which explored the utility of Horizon's advanced reference standards in Transgenomic's in vitro DNA mutation enrichment kits. The standards are being used in both quality control and mutation concentration assays.

Transgenomic's MX-ICP technology offers major advantages for users of current sequencing technologies by delivering a sensitivity improvement of at least 100-fold in comparison to standard methodologies and enriching both known and previously unknown genetic alterations using a single multiplexed assay. The ultra-high sensitivity of MX-ICP makes it feasible to conduct comprehensive genomic analyses using either tissue biopsies or liquid samples such as blood or urine.

Dr. Paul Morrill, President, Products, Horizon Discovery Group, said: "To see our relationship with Transgenomic expand into a full OEM relationship after our initial collaboration project is a strong endorsement of Horizon's expertise in this field. We are dedicated to ensuring that cutting edge molecular diagnostic assays, such as those developed by Transgenomic, can demonstrate their true clinical significance and performance. We are delighted that they have chosen to make our reference material available with every MX-ICP kit purchase. This important relationship is part of our forward strategy to drive sustainable core revenue growth as well as take a scientific leadership role in the field of personalized medicine."

"Incorporating Horizon's industry-leading controls into our MX-ICP kits supports our global commercialization campaign by providing customers and partners additional assurance of the exceptional performance of MX-ICP technology," said Paul Kinnon, Transgenomic's President and CEO. "The ultra-high sensitivity of MX-ICP enhances detection and identification of very low concentration, clinically important cancer mutations in tissue and liquid biopsies. Horizon's highly characterized and quantitative genomic DNA-based reference standards support the high performance of our MX-ICP technology. We expect that they will be especially valuable in clinical applications."

Further details of the agreement were not disclosed.

distributed by
React to this article
Latest news
Date Title
02:15a GAP : Statement of Gap Inc. on the Nepal Earthquake Disaster
02:15a HORIZON DISCOVERY : Transgenomic to incorporate Horizon Discovery’s Genomic Reference Standards into Multiplexed ICE COLD-PCR™ kits
02:13a NAT WEST B PRF NON CUM $ PRF SER'B'US$25 : TfL left a gap in my finances by taking two £1,284 payments
02:12a MANCHESTER UNITED : LVG flying the flag for Ryan heir
02:12a KELLY ON BGT : Cowell was disrespectful ; EX JUDGE LIFTS LID ON SIMON
02:12a MANCHESTER UNITED : PRIDE & GROOM ; SIR ALEX FERGUSON EXCLUSIVE UNITED: THE FUTURE Fergie wants new United boss to beat his trophy haul...and Giggs is the man
02:12a LLOYDS BANKING : ENJOY a Steakation getaway
02:11a MANCHESTER UNITED : Basque kids fit Bil for ; HOTLINE
02:11a JUVENTUS FOOTBALL CLUB : Carlo is the Man for Real
02:10a MANCHESTER UNITED : Jose must beware LVG ...Louis van Gunslinger
Latest news
Advertisement
Hot News 
GCP STUDENT LIVING : Dividend Declaration and Net Asset Valuation
AERIE PHARMACEUTICALS : Pharma plunges aftermarket as Rhopressa study fails
SYQIC : Gets Working Capital Facility Offer, Improves Cash Position
INNATE PHARMA : and AstraZeneca announce global agreement for IPH2201 in immuno-oncology
French Connection warns on full-year results
Most Read News
04/25 DEUTSCHE BANK : to keep 500 German retail branches - Welt am Sonntag
04/25 KROGER : accounting celebrates 20 years of growth in Hutchinson
04/25 MANCHESTER UNITED : Rooney, Abramovich, Branson in UK Rich List
04/25 SOLARCITY : Town of Plattsburgh exploring solar project
04/25 MICROSOFT : Forty Years and a Big Slip
Most recommended articles
12:23a Cuts to pay and perks trigger flight from China's state banks
04/25DJNepal Quake Brings Everest Avalanche -- Update
04/25 Germany hints at preparations of a Plan B on Greece
04/25 DEUTSCHE BANK : to keep 500 German retail branches - Welt am Sonntag
04/25 Ruthless Volkswagen patriarch Piech overplays last hand
Dynamic quotes  
ON
| OFF